» Articles » PMID: 30683295

Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion

Overview
Journal J Thorac Oncol
Publisher Elsevier
Date 2019 Jan 27
PMID 30683295
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?.

Spitaleri G, Trillo Aliaga P, Attili I, Del Signore E, Corvaja C, Corti C Curr Oncol. 2023; 30(5):5072-5092.

PMID: 37232842 PMC: 10217667. DOI: 10.3390/curroncol30050384.


Catalog of 5' Fusion Partners in -positive NSCLC Circa 2020.

Ou S, Zhu V, Nagasaka M JTO Clin Res Rep. 2021; 1(1):100015.

PMID: 34589917 PMC: 8474466. DOI: 10.1016/j.jtocrr.2020.100015.